Storys zum Thema Gesundheit
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Almirall S.A.: Experts highlight the need to focus on psoriasis patients' wellbeing in clinical practice
Barcelona, Spain (ots/PRNewswire) - - Psoriasis affects the overall emotional wellbeing of 88% of patients[1], and at least 20% of psoriasis patients have considered suicide[2] - Currently used endpoints in psoriasis do not capture the full impact of this skin condition on patients' lives, and almost 50% of them ...
mehrLebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic deramatitis in two Phase 3 trials
Barcelona (ots/PRNewswire) - - Primary and all key secondary endpoints including itch, interference of itch on sleep and quality of life were met at Week 16 in two pivotal Phase 3 trials - Safety profile consistent with prior lebrikizumab studies in atopic dermatitis Lebrikizumab led to significant improvements with ...
mehr- 2
Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM
mehr M3 Invests in Physicians Career Portal praktischArzt
mehrAircraft Cabin Modification GmbH
3Avital increases safety in aviation
mehr
Intelligent algorithms for movement apps: with LTech, the Lindera Software Development Kit, Berlin-based health tech company Lindera brings innovation and AI technology to the fitness industry
mehrDid my vaccine work? New rapid test for the determination of vaccination success
mehrIntroducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering people with obesity to find relevant care for a better quality of life
Berlin (ots) - The Novo Nordisk and Zur Rose Group collaboration presents DocMorris Adipositas Care, a digital hub which provides people living with obesity a new way to find the right care. Adipositas Care thoughtfully empowers people living with obesity by enabling them to learn about obesity and discover possible ...
mehrFirst pocket inhaler for Covid-19 and other viral mutations
Buochs (ots) - DG-Nika AG – a new approach to therapy & proactive protection from the pandemic The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the ...
mehrtFRWD LAUNCHES COVID-19 PCR SELF TEST TO DO AT HOME (SALIVA BASED)
Vienna (ots) - In partnership with local distributor DIVISIONCARE, tFRWD is ready to supply large numbers of the test-kits to the Portuguese. The test is done through RT.PCR and the kit is CE certified and approved by WHO with a sensitivity / specificity of 99%. This is the first Covid19 self-test solution to perform at home, completely painless, and without needing a health professional to collect the sample. Tester ...
mehrMerger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis
mehr
COVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease
Moers (ots) - Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes. An infection with ...
mehrCorona rapid test: Celebrate Christmas together without anyone getting infected
mehrSysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia
Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based, high-sensitivity molecular testing for oncology, is presenting the poster "Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel" at ...
mehrNew study: Only reliable rapid corona tests make sense
mehrEuropean Commission launches EUR 8 million Next-Generation IoT environments project amid Covid-19 pandemic
mehrNew: Combined rapid test for Covid-19 and influenza
mehr
New Covid-19 antigen test: Fast and reliable results in just 15 minutes
mehrThe mobility specialist REHASENSE cooperates with Krzysztof Pietrasik
mehrRevolutionary face mask can prevent cross-contamination
mehrFinnish coronavirus tracing app Koronavilkku reaches 2 million downloads
Helsinki (ots) - The Finnish Koronavilkku ('Corona Blinker') application, which helps to break chains of coronavirus infection, has already been downloaded over 2 million times. The milestone of 2 million downloads - 37 % of the population - was reached two weeks after the application became available for download in app stores. 'We all now have a genuine opportunity ...
mehrHARTMANN launches Mission: Infection Prevention - how prevention is contagious
mehrUMIT - The Health & Life Sciences University
University UMIT TIROL publishes the first population model to evaluate benefits and harms of universal salt iodization
Hall in Tirol (ots) - An article recently published by Schaffner and colleagues in the medical journal "Thyroid" summarizes the results of a decision-analytic population modeling study evaluating the benefits and harms of universal salt iodization. Iodine is a micronutrient that is essential for the production of ...
mehr
Sysmex Inostics' OncoBEAMTM RAS CRC testing supports clinical outcome improvements for metastatic colorectal cancer patients rechallenged with anti-EGFR therapy
Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study evaluating RAS mutation status in circulating tumor DNA (ctDNA) of colorectal cancer (CRC) patients undergoing anti-EGFR ...
mehrSysmex-Inostics Colorectal Cancer Blood-Based OncoBEAMTM RAS CE-IVD Test Shows Concordance with Standard of Care Tissue-Based RAS Testing
Baltimore, Maryland (ots) - Sysmex-Inostics, Inc., a global leader and pioneer in blood-based circulating tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study evaluating the performance of plasma RAS mutation testing with OncoBEAM RAS CRC as compared to standard of care ...
mehrForeign office of Kazakhstani opposition
Akezhan Kazhegeldin calls on President Tokayev to carry out political and economic reforms / Former Kazakh Prime Minister proposes emergency measures to overcome the current crisis
mehrThe European Court of Human Rights requests the Government of Armenia to ensure adequate medical treatment to illegally detained former statesman Gagik Khachatryan
mehrWe+Care: EUR1.5 million to increase the quality at the end of life
mehrDr. Rath Education Services BV
Micronutrient Combination Suppresses Cell 'Entry Door' For Coronavirus
mehr